ZHX1 activators encompass a spectrum of chemical compounds that indirectly enhance the functional activity of ZHX1 through a variety of signaling pathways. The activation of adenylyl cyclase by Forskolin leads to an increase in cyclic AMP (cAMP) levels, which activates protein kinase A (PKA). PKA then phosphorylates transcription factors that work in concert with ZHX1 to regulate gene expression. Similarly, IBMX prevents the breakdown of cAMP, thereby sustaining this PKA-mediated activation of ZHX1. Epigallocatechin gallate, a kinase inhibitor, can relieve ZHX1 from negative regulatory kinases, thereby promoting its transcriptional functions. Sphingosine-1-phosphate is a signaling lipid that may influence the nuclear transport or retention of ZHX1, augmenting its gene regulatory roles. The diacylglycerol analogue PMA activates PKC, which can modify co-regulators of ZHX1 to enhance its action, while A23187 increases intracellular calcium, potentially stimulating calcium-dependent proteins that alter ZHX1 activity.
On the other hand, LY294002 and PD98059, as inhibitors of PI3K and MEK respectively, may indirectly favor pathways that upregulate ZHX1 activity by reducing the activity of competing pathways such as AKT and MAPK/ERK. SB203580 and U0126, both targeting MAPK pathways, could create a signaling environment that positively influences ZHX1's transcriptional modulation by impeding the action of suppressive kinases. Additionally, Thapsigargin and Ionomycin, through their disruption of calcium homeostasis, promote calcium-dependent signaling which is crucial for the regulatory functions of ZHX1.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which may enhance ZHX1 activity by PKA activation and subsequent phosphorylation of transcription factors that cooperate with ZHX1 in gene regulation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP levels, potentially enhancing ZHX1 activity through the same pathway as Forskolin. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This polyphenol inhibits several protein kinases, potentially reducing negative regulatory influences on ZHX1 activity and promoting its DNA-binding and transcriptional activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
As a bioactive lipid, Sphingosine-1-phosphate activates signaling pathways that may lead to nuclear localization of ZHX1 and enhance its function in gene regulation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate transcriptional co-regulators that interact with ZHX1, enhancing its transcriptional activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium levels, which could activate calcium-dependent signaling pathways that modulate ZHX1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This PI3K inhibitor may shift cellular signaling in favor of pathways that enhance ZHX1 activity by reducing competitive signaling through the AKT pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As an MEK inhibitor, PD98059 could favor signaling pathways that indirectly upregulate ZHX1 activity by modulating the MAPK/ERK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor might redirect cellular signaling to enhance ZHX1 activity by reducing the p38 MAPK mediated suppression of co-factors that interact with ZHX1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, potentially increasing the activity of calcium-dependent kinases and phosphatases that modulate ZHX1 function. | ||||||